Sofinnova Partners promotes Javier Nunez-Vicandi to Partner, strengthening its Digital Medicine strategy
Physician-investor and co-builder of Sofinnova’s AI platform Sofia joins the partnership, underscoring the firm’s growing interest in healthtech and techbio
PARIS, France – November 2, 2026 — Sofinnova Partners (“Sofinnova”), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, today announced the promotion of Javier Nunez-Vicandi to Partner. He joins Edward Kliphuis and Simon Turner in the firm’s Digital Medicine strategy, which invests in startups working at the intersection of biology, data, and AI.
